A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jenna Brashear
| Share Statistics | ACXP | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $7.5 | $282.4 | 5% |
|
| Shares Out (Mil) | 4.3 | 54.0 | 13% |
|
| Institutional Ownership | 77.5% | 93.1% | 47% |
|
| Float (Mil) | 5.1 | 42.2 | 12% |
|
| Beta | -2.03 | 0.94 | 0% |
|
| Avg Daily Volume (000s) | 93 | 482 | 36% |
|
| Price Change (52-week) |
(63.2%) | 59.9% | 11% |
|
| Growth | ACXP | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 14.1% | na |
|
| Net Income (5yr) | (11.7%) | (10.1%) | 27% |
|
| EPS (5yr) | 18.6% | 15.9% | 66 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 2.8% | (15.6%) | 66% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($0.425) | ($1.925) | ($1.750) | |
| Month Ago EPS | ($0.455) | ($1.970) | ($2.130) | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 1 | 1 | |
| Three Months Ago EPS | ($0.455) | ($1.970) | ($2.130) | |
| Year/Year Chg | (19.7%) | (63.8%) | (64.3%) | |
| Financials | ACXP | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($8) | ($43) | 31% |
|
| EPS (TTM) | ($2.783) | ($1.500) | 12% |
|
| Operating Cash Flow (TTM) (Mil) | ($6) | ($31) | 23% |
|
| Net Cash Flow (TTM) (Mil) | na | $2 | na |
|
| Long-Term Debt (Q1) (Mil) | $0 | $4 | 0% |
|
| Enterprise Value (Q1) (Mil) | ($3) | $190 | 2% |
|
| Valuation | ACXP | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.82 | 2.84 | 15% |
|
| P/E | na | 20.2 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | ACXP | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 66.9% | na |
|
| Net Margin | na | (74.2%) | na |
|
| ROA | (87.6%) | (47.7%) | 6% |
|
| ROE | (128.1%) | (55.0%) | 7% |
|
| Liabilities to Assets | 25.8% | 29.8% | 18% |
|
| F-Score | 3 | 3 | 18% |
|
Acurx Pharmaceuticals, Inc. did not pass any screens on 9/4/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
